The Global Embolization Coil Market was valued at USD 863 Million in 2020 and is expected to grow at a Compound Annual Growth Rate (CAGR) of 5.3% between 2021 to 2028 according to analysts at Vantage Market Research. Embolization coils are mostly used to treat blood related condition such as cardiac aneurysm, brain aneurysm it is mostly used for an alternative to the cut supply of blood for the tumor. The embolization coil market is driven by the factors such as most usage in minimal invasive procedures and rise in the patients of cardiac aneurysm.

Since the outbreak of the COVID-19, it widely spread all over the world and has impacted many countries economy and caused huge loses in businesses. The embolization coil market is experiencing a negative growth due to lockdown imposed worldwide and low healthcare facilities. The post COVID scenarios is changing as the improvement of healthcare infrastructures has been seen.

The embolization coil market is segmented on the basis of deployment and application. The deployment type segment is further bifurcated into push-able and detachable. The detachable sector is holding the largest share and shows potential growth in future forecast. The application segment is divided as neurology, urology, oncology, and peripheral vascular disease. Based on these the neurology is the at having the largest share and potential growth for further forecasted years.

The major players for the embolization coil market are Boston Scientific Corporation, Medtronic, Cook Medical, Terumo Corporation, St. Jude Medical, DePuy Synthes, Stryker Corporation, Sirtex medical, and Cordis Corporation.

Regionally, the market is segmented as Asia-Pacific, Europe, North America, the Middle East and Africa and Latin America. North America attained the highest share due to presence of key players and government initiatives.